Jeffrey H. Lawson, M.D., Ph.D.
Chief Medical Officer
Jeffrey H. Lawson, M.D., Ph.D. received his Medical Degree and a Ph.D. in Cell and Molecular Biology from the University of Vermont in Burlington. He then completed a Postdoctoral Fellowship in Biochemistry at the same location and a residency in General and Thoracic Surgery and a Fellowship in Vascular Surgery at Duke University Medical Center in Durham, North Carolina.
Dr. Lawson was formerly Vice Chair, Professor of Surgery and Professor of Pathology at Duke University Medical Center, and also Director of the Vascular Surgery Research Laboratory and Director of Clinical Trials in Vascular Surgery. Dr. Lawson was the Program Director of the General Surgery Research Residency Program and the Medical Director of Department of Surgery Clinical Research Unit.
Dr. Lawson is a physician-scientist, clinically practicing vascular surgery and actively pursuing basic, translational and clinical research. Lawson has had a lifelong interest in the field of blood coagulation and vascular biology and has continuously studied these areas both scientifically and clinically in his laboratory. He has become a recognized leader in the field of vascular translational technology and his Duke-based laboratory has successfully developed a number of molecular, cellular and tissue engineered technologies through translational research studies to first-in-man clinical trials. He is the co-author of over 120 journal articles on the topics of hemostasis, tissue engineering and vascular surgery and lectures on these topics both nationally and internationally. Dr. Lawson’s Duke research laboratory has been funded by grants from the American Heart Association, National Institutes of Health, Department of Defense and various biotechnology companies.